This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Cryptocurrency and the Washington Nationals: Once Bitten, Twice Shy?
Grushka-Cockayne, Yael; Hachem, Kinda; Lenox, Michael; Maiden, Stephen E.;Case DARDEN-S-0393-EStrategyIn May 2022, Jennifer Chen, vice president of strategic partnerships for the Washington Nationals, faced a dilemma. Just months before, the Nationals had embarked on a high-profile sponsorship partnership with Terraform Labs, a decentralized autonomous organization that had created two cryptocurrencies, TerraUSD (UST) and Luna. The Nationals had agreed to accept the stablecoin UST as payment and had emblazoned its ballpark with Terraform Labs' lo...Starting at €8.20
-
Basware in 2013: Transistion to Software as a Service
Burgelman, R; Schifrin, DCase SGSB-SM219-EStrategyIn 2013 Basware, the Finland-based e-invoice operator and Enterprise Resource Planning (ERP) software vendor, was going through a large and critical transition: moving from selling and installing licensed software to selling Software as a Service (SaaS). Basware, which sold automated Purchase-to-Pay solutions for Business-to-Business to 2,000 Nordic and global clients, was responding to a sharp decline in those sales in the previous few years; mo...Starting at €8.20
-
Bystander Intervention: USA Gymnastics and Beyond (B)
Freeman, R. Edward; Mead, Jenny; Liedtka, Jeanne M.; Grushka-Cockayne, Yael; Santos, GraceCase DARDEN-E-0483-EBusiness Ethics and Corporate Social ResponsibilityThis partially disguised, public-sourced case, a follow-up to “Bystander Intervention: USA Gymnastics and Beyond (A)” (UVA-E-0482), details what happened after top gymnastics coach Megan Peterson reported team doctor Larry Nassar to USA Gymnastics leadership for his abuse of young athletes. It turned out that many others had tried to report Nassar for various instances of inappropriate behavior and abuse over the years, but coaches, trainers, adm...Starting at €5.74
-
Axel Springer in 2016: From Transformation to Acceleration - Teaching Note
Burgelman, R; Siegel, R; Kissick, RTeaching Note SGSB-E610TN-EEntrepreneurshipAs of 2016, Mathias Döpfner, chief executive officer (CEO) of Axel Springer SE, had successfully transitioned the German publishing house through a major digital transformation in the world of journalism. Given the massive disruption that had occurred over the previous two decades with how people consumed news, this was no small feat. During this time, many newspapers, magazines, and journals failed to keep up with the rapidly changing industry...Starting at €0.00
-
Axel Springer in 2016: From Transformation to Acceleration
Burgelman, R; Siegel, R; Kissick, RCase SGSB-E610-EEntrepreneurshipAs of 2016, Mathias Döpfner, chief executive officer (CEO) of Axel Springer SE, had successfully transitioned the German publishing house through a major digital transformation in the world of journalism. Given the massive disruption that had occurred over the previous two decades with how people consumed news, this was no small feat. During this time, many newspapers, magazines, and journals failed to keep up with the rapidly changing industry...Starting at €8.20
-
Billie Jean King: Serving Up Leadership
Freeman, R. Edward; Grushka-Cockayne, Yael; Liedtka, Jeanne M.; Mead, JennyCase DARDEN-E-0488-EBusiness Ethics and Corporate Social ResponsibilityThroughout a lifetime of athletic success, hard work, high visibility, and professional and personal challenges both on and off the tennis court, Billie Jean King, an icon of both professional tennis, business, and activism, remained deeply committed to gender equality, social parity, and justice. In tennis and beyond, King had fought many battles, overcome many challenges, and knocked down barriers in the sports world and beyond. She had promote...Starting at €8.20
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
2U: Higher Education Rewired, Teaching Note
Grushka-Cockayne, YaelTeaching Note HBS-620095-EService and Operations ManagementTeaching note for case 620044.Starting at €0.00
-
Comparing Two Groups: Sampling and t-Testing
Bojinov, Iavor; Farronato, Chiara; Grushka-Cockayne, Yael; Shih, Willy; Toffel, Michael W.Case HBS-621044-EService and Operations ManagementThis note describes sampling and t-tests, two fundamental statistical concepts.Starting at €8.20